The injectable drug, made by the pharmaceutical company Eli Lilly, has the active ingredient tirzepatide, which had been approved in May 2022 to treat type 2 diabetes under the name Mounjaro
If you struggle with losing weight and you are looking for an alternative method to manage your weight, consider Physicians Rehabilitation today
Does carnitine administration improve the symptoms attributed to anticonvulsant medications
Diabetes 12 , 124137 (2021)
Berger TM, Poldori MC, Dabbagh A, Evans PJ, Halliwell B, Morrow JD, Roberts II J, Frei B: Antioxidant activity of vitamin C in iron-overloaded human plasma
Many patients managing hormonal conditions like polycystic ovary syndrome (PCOS) or hypertension already take spironolactone while considering GLP-1 therapy for weight loss